DMD and Duchenne muscular dystrophy: One therapeutic strategy for treating DMD involves the application of antisense oligonucleotides (ASOs) to induce exon skipping of dystrophin genes, thereby eliminating the disease-inducing mutation and restoring the reading frame of the gene transcript [5,6,7,8,9].